Reducing ExacTrac intrafraction imaging uncertainty for prostate stereotactic body radiotherapy using a pre-treatment CBCT

被引:2
|
作者
Jordan, Barry [1 ]
Munoz, Luis [1 ]
Colyer, Christopher [1 ]
机构
[1] St Andrews Hosp Oncol, GenesisCare, Adelaide, SA, Australia
关键词
ExacTrac; CBCT; SBRT; Intrafraction; Prostate; IGRT; BEAM COMPUTED-TOMOGRAPHY; GUIDED RADIOTHERAPY; RADIATION-THERAPY; ORGAN MOTION; MULTIINSTITUTIONAL CONSORTIUM; GEOMETRIC ACCURACY; RADIOPAQUE MARKERS; IMPLANTED MARKERS; FIDUCIAL MARKERS; CANCER;
D O I
10.1007/s13246-022-01121-7
中图分类号
R318 [生物医学工程];
学科分类号
0831 ;
摘要
This study evaluated the intrafractional auto-matching uncertainties of prostate-implanted fiducial markers when using the ExacTrac v6.5 (Brainlab, Feldkirchen, Germany) X-ray stereoscopic system. A customised phantom with 3 implanted gold seeds was initially positioned at the isocentre using a cone beam CT (CBCT) prior to intrafractional imaging. Progressive offsets were applied to the phantom in all six directions (3 translational, 3 rotational) of 0 mm, 1 mm, 2 mm, 0 degrees, 1 degrees and 2 degrees. Subsequently, the ability of the ExacTrac image-matching functions to detect and correct these offsets was tested. For comparison, this procedure was repeated, but without a CBCT for pre-treatment positioning. The auto-matching uncertainties when a CBCT was introduced into the workflow were significantly reduced, and overall, the auto-matching statistics using the implanted marker (seeds) matching function was found to be more precise than the bony anatomy function in-phantom. The total standard deviations for the translational shifts using the implanted marker and bony anatomy functions respectively were 0.1 mm and 0.3 mm vertically, 0.1 mm and 0.3 mm longitudinally, and 0.1 mm and 0.4 mm laterally. The standard deviations for the rotational shifts using the implanted marker and bony anatomy matching functions respectively were 0.2 degrees and 1.2 degrees for the yaw (angle vert), 0.3 degrees and 1.1 degrees for the pitch (angle long), and 0.2 degrees and 1.2 degrees for the roll (angle lat) directions. The reduced uncertainties from introducing a CBCT for initial localisation resulted in decreased probability of inhibits due to false positives during treatment.
引用
收藏
页码:547 / 558
页数:12
相关论文
共 50 条
  • [31] EPID-based 3D dosimetry for pre-treatment FFF VMAT stereotactic body radiotherapy plan verification using dosimetry Check™
    Chendi, Agnese
    Botti, Andrea
    Orlandi, Matteo
    Sghedoni, Roberto
    Iori, Mauro
    Cagni, Elisabetta
    PHYSICA MEDICA-EUROPEAN JOURNAL OF MEDICAL PHYSICS, 2021, 81 : 227 - 236
  • [32] Inter and intrafraction set-up variation in the stereotactic body radiation therapy treatment of the lung under controlled breathing conditions measured using CBCT
    Malhotra, H. K.
    Podgorsak, M.
    Bakhtiari, M.
    May, K. Salerno
    Gomez, J.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2008, 72 (01): : S618 - S619
  • [33] Comparison of pre-treatment and in-vivo dosimetry for advanced radiotherapy of prostate cancer
    Bartnikowska, Agnieszka
    Cieslik, Grzegorz
    Mlodzik, Mateusz
    Garcia-Argibay, Miguel
    Pract, Rep
    REPORTS OF PRACTICAL ONCOLOGY AND RADIOTHERAPY, 2022, 27 (02) : 189 - 197
  • [34] VALIDATION OF 3D SURFACE IMAGING FOR MONITORING INTRAFRACTION MOTION IN FRAMELESS STEREOTACTIC BODY RADIOTHERAPY OF LUNG CANCER
    Betgen, A.
    Alderliesten, T.
    Heddes, R.
    Rerneijer, P.
    Sonke, J. J.
    RADIOTHERAPY AND ONCOLOGY, 2010, 96 : S80 - S80
  • [35] EFFECTIVENESS OF SURFACE-GUIDANCE IN DETECTING INTRAFRACTION MOTION FOR FRAMELESS, LINEAR ACCELERATOR-BASED STEREOTACTIC RADIOSURGERY AND FRACTIONATED STEREOTACTIC RADIOTHERAPY WHEN EVALUATED USING POST-TREATMENT CBCT
    Wong, Justina
    Snyder, Natalie
    Granillo, Valeriia
    Warkentin, Heather
    Burke, Ben
    RADIOTHERAPY AND ONCOLOGY, 2021, 163 : S69 - S69
  • [36] Reducing Errors in Prostate Tracking with an Improved Fiducial Implantation Protocol for Stereotactic Body Radiotherapy (SBRT)
    Holmes, O. E.
    Gratton, J.
    Szanto, J.
    Vandervoort, E.
    Doody, J.
    Henderson, E.
    Morgan, S. C.
    O'Sullivan, J.
    Malone, S.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2017, 99 (02): : E239 - E239
  • [37] Stereotactic body radiotherapy (SBRT) as a treatment for localized prostate cancer: a retrospective analysis
    De Cooman, Brecht
    Debacker, Tibaut
    Adams, Thomas
    Lamberts, Guy
    De Troyer, Bart
    Claessens, Marc
    De Kerf, Geert
    Mercier, Carole
    Dirix, Piet
    Ost, Piet
    RADIATION ONCOLOGY, 2025, 20 (01)
  • [38] Daily Plan Verification Before and After Treatment in Prostate Stereotactic Body Radiotherapy
    Kucukmorkoc, E.
    Kucuk, N.
    Sanli, E.
    Celebi, S.
    Canoglu, D.
    Rzazade, R.
    Turna, M.
    Caglar, H. B.
    RADIOTHERAPY AND ONCOLOGY, 2021, 161 : S1263 - S1264
  • [39] Trends in the Use of Stereotactic Body Radiotherapy for Treatment of Prostate Cancer in the United States
    Mahase, Sean S.
    D'Angelo, Debra
    Kang, Josephine
    Hu, Jim C.
    Barbieri, Christopher E.
    Nagar, Himanshu
    JAMA NETWORK OPEN, 2020, 3 (02)
  • [40] Stereotactic body radiotherapy (SBRT) for the treatment of bone metastases in oligometastasised prostate cancer
    Sage, Eva Katharina
    Vogel, Marco M. E.
    Dewes, Sabrina
    Devecka, Michal
    Eiber, Matthias
    Gschwend, Juergen E.
    Combs, Stephanie E.
    Schiller, Kilian
    AKTUELLE UROLOGIE, 2020, 51 (03) : 265 - 270